Skip to main content
Marc Wein, MD, Endocrinology, Boston, MA

Marc N Wein MD PhD

Diabetes, Lipid Metabolism


Research Fellow in Medicine, Massachusetts General Hospital

Join to View Full Profile
  • Massachusetts General Hospital55 Fruit St.Boston, MA 02114

  • Phone+1 617-726-2862

  • Fax+1 617-724-7441

Dr. Wein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2014
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2011
  • Harvard Medical School
    Harvard Medical SchoolClass of 2009

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2011 - 2026

Publications & Presentations

PubMed

Journal Articles

  • The Great Opportunity: Cultivating Scientific Inquiry in Medical Residency  
    Marc N Wein, Michael K Mansour, Jatin M Vyas, Jayaraj Rajagopal, Mark C Fishman, Kathleen E Corey, Caroline L Sokol, Katrina A Armstrong, The Journal of Infectious Diseases

Press Mentions

  • Exercise Intolerance and Low Cardiac Filling Pressures in a Woman with a Novel eNOS Mutation
    Exercise Intolerance and Low Cardiac Filling Pressures in a Woman with a Novel eNOS MutationSeptember 27th, 2024
  • Dr. Marc Wein: Extra Attention Should Be Paid to Fracture Risk in COPD Patients Receiving High-Dose Inhaled Corticosteroids
    Dr. Marc Wein: Extra Attention Should Be Paid to Fracture Risk in COPD Patients Receiving High-Dose Inhaled CorticosteroidsNovember 16th, 2020
  • SMURF2 Regulates Bone Homeostasis by Disrupting SMAD3 Interaction with Vitamin D Receptor in Osteoblasts
    SMURF2 Regulates Bone Homeostasis by Disrupting SMAD3 Interaction with Vitamin D Receptor in OsteoblastsFebruary 20th, 2017
  • Join now to see all

Grant Support

  • Center of Research Translation on Osteoporosis Bone Anabolic TherapiesMASSACHUSETTS GENERAL HOSPITAL2023–2027
  • Center of Research Translation on Osteoporosis Bone Anabolic TherapiesMASSACHUSETTS GENERAL HOSPITAL2023–2027
  • The role of salt inducible kinases in parathyroid hormone action in boneMASSACHUSETTS GENERAL HOSPITAL2018–2027

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: